Speeding up early drug development

Drug aliquots for R&D

Therapeutic molecules of clinical-grade quality. From 1 mg. Ready to ship.

Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products

aliquoted from medicines

Drug Aliquots

In Stock

Download | In-stock aliquots

Drug Aliquots

On Demand

Download | On-demand aliquots

Your Desired

Molecule

best selling products

molecular classes

NEW BATCHES

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Quantity per vial	Expiry Date	Price
Adalimumab 1120078A	TNF alpha	Biosimilar , Monoclonal Antibody	Amgevita®	2 mg	12/2021	265,50 €	Max: 10 Min: 1 Step: 1
Adalimumab 1163571	TNF alpha	Monoclonal Antibody	Humira®	4 mg	11/2023	438,00 €	Max: 10 Min: 1 Step: 1
Adalimumab 1825216	TNF alpha	Biosimilar , Monoclonal Antibody	Hulio®	2 mg	02/2023	265,50 €	Max: 10 Min: 1 Step: 1
Adalimumab 1909689A	TNF alpha	Biosimilar , Monoclonal Antibody	Hukyndra®	2 mg	10/2023	344,00 €	Max: 10 Min: 1 Step: 1
Adalimumab 28209AS14	TNF alpha	Monoclonal Antibody	Humira®	4 mg	03/2023	394,20 €	Max: Min: 1 Step: 1
Adalimumab 2LJPO1T11	TNF alpha	Biosimilar , Monoclonal Antibody	Yuflyma®	4 mg	02/2024	344,00 €	Max: 10 Min: 1 Step: 1
Adalimumab 70225XH07	TNF alpha	Monoclonal Antibody	Humira®	4 mg	09/2018	394,20 €	Max: 5 Min: 1 Step: 1
Adalimumab 73254XH03	TNF alpha	Monoclonal Antibody	Humira®	4 mg	12/2018	394,20 €	Max: 10 Min: 1 Step: 1
Adalimumab 76287XH07	TNF alpha	Monoclonal Antibody	Humira®	4 mg	03/2019	394,20 €	Max: 10 Min: 1 Step: 1
Adalimumab 76287XH11	TNF alpha	Monoclonal Antibody	Humira®	4 mg	03/2019	394,20 €	Max: 10 Min: 1 Step: 1

1 2

Evidentic – fast, accurate, secure

Our products are empowering researchers worldwide

"After having great difficulty sourcing therapeutic antibodies in the small quantities required for research purposes, Evidentic has been a revelation! I have found them to be very friendly and prompt in replying to orders and queries. The online catalogue is very convenient and makes the ordering process easy and rapid. Having the products pre-reconstituted and aliquoted in a GMP Laboratory is also extremely helpful. In terms of service, delivery times and communication I rate them very highly."

Dr. Cassey McRae

Senior R&D Scientist at Avacta Life Sciences

"Evidentic gives rapid access to originator biologics and different batches. For biosimilar developers and regulators, it will shorten the time to gauge the analytical acceptance range for multiple CQAs of biotherapeutics."

Prof. Dr. Henning von Horsten

Life Science Engineering, HTW Berlin

“Evidentic was the only source that offered small aliquots of original therapeutic mAbs at an affordable price range. The aliquots came in an easy-to-use-and-store format that was apt for my research purpose.”

Ivanna Hrynchak

PhD Student ICNAS, Universidade de Coimbra

“We develop innovative and biosimilar mAbs for a global market. Evidentic’s aRMPs are a great source of cost-efficient reference products for our research and development program.”

Tom H. Jin, M.D.

Director of Process Development

"Evidentic is a new source of cost-efficient therapeutic mAbs for our immonassays. And easy to order!”

Thibault Jonckheere

CEO

"Evidentic drug aliquots have helped us speed up our antibody characterization assays and selection of clonal cell lines. An easy and reliable source!"

Prof. (emeritus) Dr. Florian Wurm 

CSO & Founder

”Evidentic can supply different batches of reference products for pre-clinical research. The quick access to the in-stock batches allows for ad-hoc ordering, keeps costs down and makes a headstart possible!”

Anjan Selz

Vice President
Head of Biosimilars EMEA

“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”

Dr Stephan Schultz

Team Leader of Analytics/DSP

Why buy aliquots?

Evidentic is a young innovative company providing original drugs for research and new drug development.

Through our unique concept, we enable our customers to buy small quantities of these drugs as consumables, saving costs and time.

Speeding up early drug development

Drug aliquots for R&D

Therapeutic molecules of clinical-grade quality. From 1 mg. Ready to ship.

Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products

aliquoted from medicines

Drug Aliquots

Drug Aliquots

Your Desired

best selling products

molecular classes

NEW BATCHES

Enfortumab Vedotin

Aldesleukin

Gemtuzumab ozogamicin

Avalglucosidase alfa

Alglucosidase alfa

Emicizumab

Brentuximab Vedotin

Trastuzumab deruxtecan

Risankizumab

Ocrelizumab

Evidentic – fast, accurate, secure

Our products are empowering researchers worldwide​

Dr. Cassey McRae

Senior R&D Scientist at Avacta Life Sciences

Prof. Dr. Henning von Horsten

Life Science Engineering, HTW Berlin

Ivanna Hrynchak

PhD Student ICNAS, Universidade de Coimbra

Tom H. Jin, M.D.

Director of Process Development

Thibault Jonckheere

CEO

Prof. (emeritus) Dr. Florian Wurm

CSO & Founder

Anjan Selz

Vice President Head of Biosimilars EMEA

Dr Stephan Schultz

Team Leader of Analytics/DSP

Recent Articles

Why buy aliquots?

Evidentic is a young innovative company providing original drugs for research and new drug development.

Our products are empowering researchers worldwide

Prof. (emeritus) Dr. Florian Wurm 

Vice President
Head of Biosimilars EMEA